Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz‐Bouet, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 812-839
Open Access | Times Cited: 65

Showing 26-50 of 65 citing articles:

Evaluation of Anticholinesterase Activity of the Fungicides Mefentrifluconazole and Pyraclostrobin
Dora Kolić, Goran Šinko
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6310-6310
Open Access | Times Cited: 2
Natural phenol carbamates: Selective BuChE/FAAH dual inhibitors show neuroprotection in an Alzheimer’s disease mouse model
Kuanrong Rong, Ziyun Li, Jinhui Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117003-117003
Closed Access | Times Cited: 2
Development of novel 2-aminoalkyl-6-(2-hydroxyphenyl)pyridazin-3(2H)-one derivatives as balanced multifunctional agents against Alzheimer's disease
Yichun Shi, Heng Zhang, Qing Song, et al.
European Journal of Medicinal Chemistry (2022) Vol. 230, pp. 114098-114098
Closed Access | Times Cited: 13
Novel coumarin benzamides as potent and reversible monoamine oxidase-B inhibitors: Design, synthesis, and neuroprotective effects
Ashraf K. El‐Damasy, Jong‐Min Oh, Hyun Ji Kim, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106939-106939
Closed Access | Times Cited: 6
Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐a]thiazolo[5,4‐d]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease
Yan Zeng, Lifei Nie, Liu Liu, et al.
Journal of Heterocyclic Chemistry (2022) Vol. 59, Iss. 6, pp. 1086-1101
Closed Access | Times Cited: 10
Comparative In Vitro and In Silico Enzyme Inhibitory Screening of Rosa x damascena and Pelargonium graveolens Essential Oils and Geraniol
Ayşe Esra Karadağ, Sevde Nur Biltekin, Betül Demırcı, et al.
Plants (2023) Vol. 12, Iss. 18, pp. 3296-3296
Open Access | Times Cited: 5
Synthesis and biological evaluation of capsaicin analogues as antioxidant and neuroprotective agents
Mao Xie, Huixian Wu, Jing Bian, et al.
RSC Advances (2023) Vol. 13, Iss. 46, pp. 32150-32159
Open Access | Times Cited: 5
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties
Giselle de Andrade Ramos, Andressa Souza de Oliveira, Manuela Bartolini, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 7, pp. 1154-1163
Open Access | Times Cited: 13
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
Caterina Pont, Tiziana Ginex, Christian Griñán‐Ferré, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113779-113779
Open Access | Times Cited: 13
Neurotoxicant effects of bisphenol A, nonylphenol, and tert‑butyl phenol in the Nile tilapia (Oreochromis niloticus)
Armando Vega‐López, Israel Lara-Vega, Genaro Atonal-Brioso, et al.
Aquatic Toxicology (2024) Vol. 268, pp. 106868-106868
Closed Access | Times Cited: 1
Carltonine-derived compounds for targeted butyrylcholinesterase inhibition
Filip Pidaný, Jana Křoustková, Jaroslav Jenčo, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1601-1625
Open Access | Times Cited: 1
Design, synthesis, biological evaluation of a new tricyclicthiazolopy‐rimidinone derivatives as acetylcholinesterase inhibitors
Yan Zeng, Lifei Nie, Liu Liu, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 10, pp. 1542-1553
Closed Access | Times Cited: 1
Fluorosulfate-containing pyrazole heterocycles as selective BuChE inhibitors: structure-activity relationship and biological evaluation for the treatment of Alzheimer’s disease
Huanhuan Li, Chengyao Wu, Shilong Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2099-2111
Open Access | Times Cited: 8
Antioxidant activity, enzyme inhibition, electrochemical and theoretical evaluation of novel PEPPSI type N-heterocyclic carbene complexes
Neslihan Şahin, Mutlu Sönmez Çelebi, Melek Çöl Ayvaz, et al.
Inorganic Chemistry Communications (2022) Vol. 145, pp. 110028-110028
Closed Access | Times Cited: 8
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
Triana Espinosa-Jiménez, Amanda Cano, Elena Sánchez‐López, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Huperzine alkaloids: forty years of total syntheses
Bichu Cheng, Lili Song, Fen‐Er Chen
Natural Product Reports (2023) Vol. 41, Iss. 1, pp. 59-84
Closed Access | Times Cited: 4
Multitarget Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: An Opportunity or an illusion?
María João Matos
Future Medicinal Chemistry (2021) Vol. 13, Iss. 15, pp. 1301-1309
Closed Access | Times Cited: 11
Synthesis and cholinesterase inhibitory activity study of Amaryllidaceae alkaloid analogues with N-methyl substitution
Petr Jansa, Ivan Barvı́k, Daniela Hulcová, et al.
Organic & Biomolecular Chemistry (2022) Vol. 20, Iss. 19, pp. 3960-3966
Closed Access | Times Cited: 7
In vitro and in vivo biological evaluation of newly synthesized multi-target 20(R)-panaxadiol derivatives for treating Alzheimer's disease
Lei Pang, Jin Li, Zheng Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114825-114825
Closed Access | Times Cited: 7
Molecular mechanisms of Alzheimer's disease: From therapeutic targets to promising drugs
Elif Alan, Zeliha Kerry, Gülnur Sevin
Fundamental and Clinical Pharmacology (2022) Vol. 37, Iss. 3, pp. 397-427
Closed Access | Times Cited: 6
Role of Computational Modeling in Drug Discovery for Alzheimer’s Disease
Mange Ram Yadav, Prashant R. Murumkar, Rahul Barot, et al.
Challenges and advances in computational chemistry and physics (2023), pp. 57-107
Closed Access | Times Cited: 3
Review of triazole scaffolds for treatment and diagnosis of Alzheimer's disease
Qi Li, Shulei Qi, Jinxin Liang, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110623-110623
Closed Access | Times Cited: 3
In vitro and in silico cholinesterase inhibitory potential of metabolites from Laurencia snackeyi (Weber-van Bosse) M. Masuda
Kishneth Palaniveloo, Kuan Hung Ong, Herland Satriawan, et al.
3 Biotech (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 3
Huprine Y – Tryptophan heterodimers with potential implication to Alzheimer’s disease treatment
Eva Mezeiová, Martina Hrabinová, Vendula Hepnarová, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 43, pp. 128100-128100
Closed Access | Times Cited: 7
In silico and in vitro assessment of the anti-β-amyloid aggregation and anti-cholinesterase activities of Ptaeroxylon obliquum and Bauhinia bowkeri extracts
Michael C. Ojo, Rebamang A. Mosa, Foluso Oluwagbemiga Osunsanmi, et al.
Electronic Journal of Biotechnology (2023) Vol. 68, pp. 67-80
Open Access | Times Cited: 2

Scroll to top